Study to Assess VB-201 in Patients With Psoriasis
Clinical trial NCT01001468 · COMPLETED
Trial details
- NCT number
- NCT01001468
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-07-01
- Enrollment
- 185
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.